Result Summary for 102115
| Protocol ID: | 102115 |
| Clinical Study ID: | 102115 |
| Official Title: | A dose-range study to assess the safety & immunogenicity of a novel HPV vaccine when administered intramuscularly according to a 3-dose schedule (0,1,6-mth) in healthy adult females (18-25 yrs of age) |
| Phase: | phase 2 |
| Study Indications or Diseases: |
|
| Generic Name: | GSK568893A |
| Trade/Product Name: | GSK568893A |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
